title: The non-anticoagulation costs of atrial fibrillation management: findings from an observational study in NHS Primary Care.
abstract: BACKGROUND
  Atrial fibrillation (AF) management represents a significant burden on the UK NHS. Understanding this burden will be important in informing future health care planning and policy development.
  
  
  OBJECTIVE
  To describe the non-anticoagulation costs associated with AF management in routine UK clinical practice.
  A retrospective observational study of 825 patients with AF undertaken in eight UK primary care practices. Data collected from routine clinical and prescribing records of all eligible, consenting patients, for a period of up to 3 years. The first 12 weeks following diagnosis was defined as the 'initiation phase'; the period after week 12 was defined as the 'maintenance phase'.
  
  
  RESULTS
  Mean (SD) total cost of AF management was £941 (£1094) per patient in the initiation phase and £426 (£597) per patient-year in the maintenance phase. AF-related inpatient admissions contributed most to total costs; the mean (SD) total cost per patient in the initiation phase was £2285 (£900) for admitted and £278 (£252) for non-admitted patients. Mean maintenance phase costs per year were £1323 (£755) and £168 (£234), respectively, for admitted and non-admitted patients. Significant patient variables contributing to high cost in the initiation phase were hypertension and younger patient age, although only accounting for 6% of cost variability. Significant variables in the maintenance phase (18% of cost variability) were the presence of congestive heart failure, structural heart disease or diabetes and the frequency of day case admissions, ECGs and hospitalisations in the initiation phase.
  
  
  CONCLUSIONS
  Inpatient admissions contributed most to total AF management costs. Given the burden of hospital care, future work should focus on evaluating the appropriateness and reasons for hospitalisation in patients with AF and the factors affecting length of stay, with the aim of identifying opportunities to safely reduce inpatient costs. A number of significant patient characteristics and initiation phase variables were identified, which accounted for 18% of the variability in total maintenance phase costs. However, none of these could adequately predict high maintenance phase costs.
authors.affiliation: The Ringmead Medical Practice, Bracknell, UK;
authors.forename: George
authors.initials: G
authors.lastname: Kassianos
authors.affiliation: Park Surgery, Chandlers Ford, UK;
authors.forename: Chris
authors.initials: C
authors.lastname: Arden
authors.affiliation: Sanofi, Guildford, UK;
authors.forename: Simon
authors.initials: S
authors.lastname: Hogan
authors.affiliation: pH Associates Ltd, Marlow, UK;
authors.forename: Laura
authors.initials: L
authors.lastname: Baldock
authors.affiliation: Carmel Medical Practice, Darlington, UK.
authors.forename: Ahmet
authors.initials: A
authors.lastname: Fuat
keywords: atrial fibrillation; health care costs; observational study; primary health care; resource use
references.citation: Clin Endocrinol (Oxf). 2003 Jan;58(1):20-1
references.pmid: 12519407
references.citation: Europace. 2011 Jan;13(1):23-30
references.pmid: 20823043
references.citation: Circulation. 2000 Sep 5;102(10):1126-31
references.pmid: 10973841
references.citation: JAMA. 2001 May 9;285(18):2370-5
references.pmid: 11343485
references.citation: Lancet. 2001 Oct 13;358(9289):1213-7
references.pmid: 11675057
references.citation: BMJ. 2005 Nov 5;331(7524):1057
references.pmid: 16216821
references.citation: Europace. 2008 Apr;10(4):403-11
references.pmid: 18326853
references.citation: J Cardiovasc Electrophysiol. 2007 Jun;18(6):628-33
references.pmid: 17451468
references.citation: Value Health. 2009 Mar-Apr;12(2):293-301
references.pmid: 18657103
references.citation: N Engl J Med. 1998 Sep 24;339(13):861-7
references.pmid: 9744969
references.citation: Am Heart J. 2004 Jan;147(1):121-6
references.pmid: 14691429